Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 71

    1.

    Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

    Kern TS, Engerman RL.

    Diabetes. 2001 Jul;50(7):1636-42.PMID: 11423486 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Retinal glutamate in diabetes and effect of antioxidants.

    Kowluru RA, Engerman RL, Case GL, Kern TS.

    Neurochem Int. 2001 Apr;38(5):385-90.PMID: 11222918 [PubMed - indexed for MEDLINE]Related articles

    3.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.

    Kowluru RA, Engerman RL, Kern TS.

    Curr Eye Res. 2000 Oct;21(4):814-9.PMID: 11120572 [PubMed - indexed for MEDLINE]Related articles

    4.

    Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy.

    Kowluru RA, Engerman RL, Kern TS.

    Free Radic Res. 2000 Jan;32(1):67-74.PMID: 10625218 [PubMed - indexed for MEDLINE]Related articles

    5.

    Aldose reductase and the development of renal disease in diabetic dogs.

    Kern TS, Engerman RL.

    J Diabetes Complications. 1999 Jan-Feb;13(1):10-6.PMID: 10232704 [PubMed - indexed for MEDLINE]Related articles

    7.

    Retinopathy and tissue hexose in drug-treated animals.

    Engerman RL, Kern TS.

    Arch Ophthalmol. 1998 Apr;116(4):543-4. No abstract available. PMID: 9565062 [PubMed - indexed for MEDLINE]Related articles

    8.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.

    Kowluru RA, Jirousek MR, Stramm L, Farid N, Engerman RL, Kern TS.

    Diabetes. 1998 Mar;47(3):464-9.PMID: 9519755 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.

    Kowluru RA, Kern TS, Engerman RL.

    Free Radic Biol Med. 1997;22(4):587-92.PMID: 9013121 [PubMed - indexed for MEDLINE]Related articles

    10.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.

    Kowluru RA, Kern TS, Engerman RL, Armstrong D.

    Diabetes. 1996 Sep;45(9):1233-7.PMID: 8772728 [PubMed - indexed for MEDLINE]Related articles

    11.

    A mouse model of diabetic retinopathy.

    Kern TS, Engerman RL.

    Arch Ophthalmol. 1996 Aug;114(8):986-90.PMID: 8694735 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen.

    Nagaraj RH, Kern TS, Sell DR, Fogarty J, Engerman RL, Monnier VM.

    Diabetes. 1996 May;45(5):587-94.PMID: 8621008 [PubMed - indexed for MEDLINE]Related articles

    13.

    Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.

    Kern TS, Engerman RL.

    Arch Ophthalmol. 1996 Mar;114(3):306-10.PMID: 8600891 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comment on the DCCT report. Diabetes Control and Complications Trial.

    Engerman RL, Kern TS.

    Diabetes. 1996 Feb;45(2):270. No abstract available. PMID: 8549874 [PubMed - indexed for MEDLINE]Related articles

    15.

    Retinopathy in animal models of diabetes.

    Engerman RL, Kern TS.

    Diabetes Metab Rev. 1995 Jul;11(2):109-20. Review. No abstract available. PMID: 7555563 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vascular lesions in diabetes are distributed non-uniformly within the retina.

    Kern TS, Engerman RL.

    Exp Eye Res. 1995 May;60(5):545-9.PMID: 7615020 [PubMed - indexed for MEDLINE]Related articles

    17.

    Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.

    Engerman RL, Kern TS.

    Arch Ophthalmol. 1995 Mar;113(3):355-8.PMID: 7887850 [PubMed - indexed for MEDLINE]Related articles

    18.

    Galactose-induced retinal microangiopathy in rats.

    Kern TS, Engerman RL.

    Invest Ophthalmol Vis Sci. 1995 Feb;36(2):490-6.PMID: 7843917 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.

    Kern TS, Engerman RL.

    Curr Eye Res. 1994 Dec;13(12):863-7.PMID: 7720392 [PubMed - indexed for MEDLINE]Related articles

    21.

    Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.

    Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL.

    Diabetes. 1994 Sep;43(9):1122-9.PMID: 8070612 [PubMed - indexed for MEDLINE]Related articles

    22.

    Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione.

    Kern TS, Kowluru RA, Engerman RL.

    Invest Ophthalmol Vis Sci. 1994 Jun;35(7):2962-7.PMID: 8206713 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.

    Engerman RL, Kern TS, Larson ME.

    Diabetologia. 1994 Feb;37(2):141-4.PMID: 8163047 [PubMed - indexed for MEDLINE]Related articles

    24.

    Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.

    Engerman RL, Kern TS, Garment MB.

    J Diabetes Complications. 1993 Oct-Dec;7(4):241-5.PMID: 8219367 [PubMed - indexed for MEDLINE]Related articles

    25.

    Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.

    Engerman RL, Kern TS.

    Diabetes. 1993 Jun;42(6):820-5.PMID: 8495805 [PubMed - indexed for MEDLINE]Related articles

    26.

    Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.

    Kern TS, Engerman RL.

    Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3175-7.PMID: 1748548 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Renal hemodynamics in experimentally galactosemic dogs and diabetic dogs.

    Kern TS, Engerman RL.

    Metabolism. 1991 May;40(5):450-4.PMID: 1902544 [PubMed - indexed for MEDLINE]Related articles

    28.

    Arrest of glomerulopathy in diabetic dogs by improved glycaemic control.

    Kern TS, Engerman RL.

    Diabetologia. 1990 Sep;33(9):522-5.PMID: 2253827 [PubMed - indexed for MEDLINE]Related articles

    29.

    Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia.

    Engerman RL, Kern TS, Larson ME.

    Metabolism. 1990 Jun;39(6):638-40.PMID: 2352480 [PubMed - indexed for MEDLINE]Related articles

    30.

    Pathogenesis of diabetic retinopathy.

    Engerman RL.

    Diabetes. 1989 Oct;38(10):1203-6. Review.PMID: 2676655 [PubMed - indexed for MEDLINE]Related articles

    31.

    Comparison of DNA breaks in diabetic dogs and galactosemic dogs developing retinopathy.

    Kern TS, Engerman RL.

    Curr Eye Res. 1989 Aug;8(8):765-9.PMID: 2791624 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemia.

    Engerman RL, Kern TS.

    Kidney Int. 1989 Jul;36(1):41-5.PMID: 2811056 [PubMed - indexed for MEDLINE]Related articles

    33.

    Elevated blood viscosity in alloxan diabetic dogs and experimentally galactosemic dogs.

    Kern TS, Engerman RL, Peterson CM.

    J Diabet Complications. 1989 Jul-Sep;3(3):158-62.PMID: 2528559 [PubMed - indexed for MEDLINE]Related articles

    34.

    Inability to detect parasympathetic autonomic neuropathy in experimental canine diabetes mellitus in an electrocardiographic study.

    Atkins CE, Keene BW, Engerman RL.

    Diabetes Res. 1989 May;11(1):39-43.PMID: 2620484 [PubMed - indexed for MEDLINE]Related articles

    35.

    Urinary protein excretion rates in experimentally diabetic dogs and experimentally galactosaemic dogs.

    Kern TS, Engerman RL.

    Diabetologia. 1988 Dec;31(12):928-32.PMID: 3240845 [PubMed - indexed for MEDLINE]Related articles

    36.

    Progression of incipient diabetic retinopathy during good glycemic control.

    Engerman RL, Kern TS.

    Diabetes. 1987 Jul;36(7):808-12.PMID: 3556280 [PubMed - indexed for MEDLINE]Related articles

    37.

    Kidney morphology in experimental hyperglycemia.

    Kern TS, Engerman RL.

    Diabetes. 1987 Feb;36(2):244-9.PMID: 3803734 [PubMed - indexed for MEDLINE]Related articles

    38.

    Is diabetic retinopathy preventable?

    Engerman RL, Kern TS.

    Int Ophthalmol Clin. 1987 Winter;27(4):225-9. No abstract available. PMID: 3319932 [PubMed - indexed for MEDLINE]Related articles

    39.

    Microvascular metabolism in diabetes.

    Kern TS, Engerman RL.

    Metabolism. 1986 Apr;35(4 Suppl 1):24-7.PMID: 3083206 [PubMed - indexed for MEDLINE]Related articles

    40.

    Hyperglycemia as a cause of diabetic retinopathy.

    Engerman RL, Kern TS.

    Metabolism. 1986 Apr;35(4 Suppl 1):20-3.PMID: 3083205 [PubMed - indexed for MEDLINE]Related articles

    41.

    Corneal endothelial changes in diabetic dogs.

    Yee RW, Matsuda M, Kern TS, Engerman RL, Edelhauser HF.

    Curr Eye Res. 1985 Jul;4(7):759-66.PMID: 4028800 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diabetic retinopathy: is it a consequence of hyperglycaemia?

    Engerman RL, Kern TS.

    Diabet Med. 1985 May;2(3):200-3. No abstract available. PMID: 2952421 [PubMed - indexed for MEDLINE]Related articles

    43.

    Hexitol production by canine retinal microvessels.

    Kern TS, Engerman RL.

    Invest Ophthalmol Vis Sci. 1985 Mar;26(3):382-4.PMID: 3972519 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Platelet aggregation in experimental diabetes and experimental galactosemia.

    Kern TS, Engerman RL.

    Diabetes. 1984 Sep;33(9):846-50.PMID: 6381180 [PubMed - indexed for MEDLINE]Related articles

    45.

    Retinal oxygen tension in diabetic dogs following insulin infusion.

    Goldstick TK, Ernest JT, Engerman RL.

    Adv Exp Med Biol. 1984;169:661-70.PMID: 6375300 [PubMed - indexed for MEDLINE]Related articles

    46.

    Experimental galactosemia produces diabetic-like retinopathy.

    Engerman RL, Kern TS.

    Diabetes. 1984 Jan;33(1):97-100.PMID: 6360771 [PubMed - indexed for MEDLINE]Related articles

    47.

    Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs.

    Ernest JT, Goldstick TK, Engerman RL.

    Invest Ophthalmol Vis Sci. 1983 Jul;24(7):985-9.PMID: 6862799 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Abnormal amino acid concentrations in plasma and urine of experimentally diabetic dogs.

    Kern TS, Engerman RL.

    Res Exp Med (Berl). 1983;182(3):185-92.PMID: 6137039 [PubMed - indexed for MEDLINE]Related articles

    49.

    Epithelial and mesothelial basement membranes in diabetic patients and dogs.

    Engerman RL, Colquhoun PJ.

    Diabetologia. 1982 Dec;23(6):521-4.PMID: 7152162 [PubMed - indexed for MEDLINE]Related articles

    50.

    Immunohistochemical distribution of aldose reductase.

    Kern TS, Engerman RL.

    Histochem J. 1982 May;14(3):507-15.PMID: 6811508 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...